// App-Quantinova.ai

: Distinct Clinico-Molecular Arterial and Venous Thrombotic Scoring Systems for MPN Patients Risk Stratification

Researchers

Presenter

  • Hélène Pasquer

Principal Investigators

  • Rafael Daltro De Oliveira

  • Juliette Soret

  • Nabih Maslah

  • Lin-Pierre Zhao

  • Clemence Marcault

  • Marine Cazaux

  • Nicolas Gauthier

  • Emmanuelle Verger

  • Nathalie Parquet

  • William Vainchenker

  • Emmanuel Raffoux

  • Stephane Giraudier

  • Bruno Cassinat

  • Jean-Jacques Kiladjian

  • Lina Benajiba

Medical Centers

  • Centre d'Investigations Cliniques, INSERM CIC , Université Paris Cité, APHP, Hôpital Saint-Louis, Paris, France

  • INSERM UMR , Institut de Recherche Saint-Louis, Paris, France

  • Laboratoire de Biologie Cellulaire, Université Paris Cité, APHP, Hôpital Saint-Louis, Paris, France

  • Département d'hématologie et d'Immunologie, Université Paris Cité, APHP, Hôpital Saint-Louis, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Myeloid neoplasms

  • Myocardial infarction

  • Essential thrombocythemia

  • Transient Ischemic Attack

  • Transient ischemic attack

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Deep vein thrombosis

  • Polycythemia vera

  • Venous thrombosis

  • Myelofibrosis

  • Stroke

Biomarkers

  • DNA methyltransferase 3 alpha

  • Tet methylcytosine dioxygenase 2

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Interferon alpha

  • Hydroxyurea

  • Hydroxycarbamide

  • Ruxolitinib phosphate

  • Interferon

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved